Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations

Emily Walvoord, Ora Hirsch Pescovitz

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.

Original languageEnglish
Pages (from-to)1010-1014
Number of pages5
JournalPediatrics
Volume104
Issue number4 II
StatePublished - Oct 1999

Fingerprint

Precocious Puberty
Growth Hormone-Releasing Hormone
Gonadotropin-Releasing Hormone
Growth Hormone
Therapeutics
Central Precocious Puberty

Keywords

  • Combination therapy
  • Gonadotropin-releasing hormone
  • Growth hormone
  • Precocious puberty

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty : Theoretic and practical considerations. / Walvoord, Emily; Pescovitz, Ora Hirsch.

In: Pediatrics, Vol. 104, No. 4 II, 10.1999, p. 1010-1014.

Research output: Contribution to journalArticle

@article{284326073cd04836b80ab72eb9a1371c,
title = "Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations",
abstract = "The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.",
keywords = "Combination therapy, Gonadotropin-releasing hormone, Growth hormone, Precocious puberty",
author = "Emily Walvoord and Pescovitz, {Ora Hirsch}",
year = "1999",
month = "10",
language = "English",
volume = "104",
pages = "1010--1014",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4 II",

}

TY - JOUR

T1 - Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty

T2 - Theoretic and practical considerations

AU - Walvoord, Emily

AU - Pescovitz, Ora Hirsch

PY - 1999/10

Y1 - 1999/10

N2 - The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.

AB - The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.

KW - Combination therapy

KW - Gonadotropin-releasing hormone

KW - Growth hormone

KW - Precocious puberty

UR - http://www.scopus.com/inward/record.url?scp=0032875673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032875673&partnerID=8YFLogxK

M3 - Article

C2 - 10506253

AN - SCOPUS:0032875673

VL - 104

SP - 1010

EP - 1014

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4 II

ER -